NF-κB is activated and promotes cell death in focal, cerebral ischemia

Nature Medicine

Volumn 5, Issue 5, 1999, Pages 554-559

  Schneider, Armin ^a,b   Martin Villalba, Ana ^a,c   Weih, Falk ^d   Vogel, Johannes ^e   Wirth, Thomas ^c   Schwaninger, Markus ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Axaron Bioscience AG   (Germany)

^c Department of Physiology ^*

^d KARLSRUHE INSTITUTE OF TECHNOLOGY   (Germany)

^e Inst of Radiobiol and Cell Res   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR RELA;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; GENE EXPRESSION; KNOCKOUT MOUSE; MOUSE; NERVE CELL NECROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; RAT; STROKE; TRANSGENE; ANIMAL; BRAIN; BRAIN ARTERY; BRAIN INFARCTION; CELL DEATH; CEREBROVASCULAR DISEASE; CYTOLOGY; DISEASE MODEL; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; MOUSE MUTANT; NERVE CELL; PATHOLOGY; PROTEIN BINDING; REPORTER GENE;

ANIMALS; BRAIN; BRAIN ISCHEMIA; CELL DEATH; CEREBRAL ARTERIES; CEREBRAL INFARCTION; CEREBROVASCULAR DISORDERS; DISEASE MODELS, ANIMAL; GENES, REPORTER; MICE; MICE, KNOCKOUT; NEURONS; NF-KAPPA B; NF-KAPPA B P50 SUBUNIT; PROTEIN BINDING; TRANSCRIPTION FACTOR RELA; TRANSGENES;

EID: 0032587072     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/8432     Document Type: Article

References (46)

1. International stroke trial collaborative group. The international stroke trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischemic stroke. Lancet 349, 1569-1581 (1997).
2. Li, Y. et al. Ultrastructural and light microscopic evidence of apoptosis after middle cerebral artery occlusion in the rat. Am. J. Pathol. 146, 1045-1051 (1995).
3. Namura, S. et al. Activation and cleavage of caspase-3 in apoptosis induced by experimental cerebral ischemia. J. Neurosci. 18, 3659-3668 (1998).
4. Endres, M. et al. Attenuation of delayed neuronal death after mild focal ischemia in mice by inhibition of the caspase family. J. Cereb. Blood Flow Metab. 18, 238-247 (1998).
5. Baichwal, V.R. & Baeuerle, P.A. Apoptosis: Activate NF-κB or die ? Curr. Biol. 7, R94-96 (1997).
6. O'Neill, L.A. & Kaltschmidt, C. NF-κB: a crucial transcription factor for glial and neuronal cell function. Trends Neurosci. 20, 252-258 (1997).
7. Kaltschmidt, C., Kaltschmidt, B., Neumann, H., Wekerle, H. & Baeuerle, P.A. Constitutive NF-κB activity in neurons. Mol. Cell. Biol. 14, 3981-3992 (1994).
8. Schmidt-Ullrich, R. et al. NF-κB activity in transgenic mice: developmental regulation and tissue specificity. Development 122, 2117-2128 (1996).
9. Guerrini, L., Blasi, F. & Denis-Donini, S. Synaptic activation of NF-κB by glutamate in cerebellar granule neurons in vitro. Proc. Natl. Acad. Sci. USA 92, 9077-9081 (1995).
10. Rong, Y. & Baudry, M. Seizure activity results in a rapid induction of NF-κB in adult but not juvenile rat limbic structures. J. Neurochem. 67, 662-668 (1996).
11. Kaltschmidt, C., Kaltschmidt, B. & Baeuerle, P.A. Stimulation of ionotropic glutamate receptors activates transcription factor NF-κB in primary neurons. Proc. Natl. Acad. Sci. USA 92, 9618-9622 (1995).
12. Baeuerle, P. & Henkel, T. Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12, 141-179 (1994).
13. Baldwin, A.S.J. The NF-κB and IκB proteins: New discoveries and insights. Annu. Rev. Immunol 14, 649-681 (1996).
14. Lernbecher, T., Müller, U. & Wirth, T. Distinct NF-κB/Rel transcription factors are responsible for tissue-specific and inducible gene activation. Nature 365, 767-770 (1993).
15. Schneider, A., Griffiths, I.R., Readhead, C. & Nave, K.-A. Dominant-negative action of the jimpy mutation in mice complemented with an autosomal transgene for myelin proteolipid protein. Proc. Natl. Acad. Sci. USA 92, 4447-4451 (1995).
16. Kaltschmidt, C., Kaltschmidt, B., Henkel, T., Stockinger, H. & Baeuerle, P.A. Selective recognition of the activated form of transcription factor NF-κB by a monoclonal antibody. Biol. Chem. Hoppe-Seyler 376, 9-16 (1995).
17. Clark, W.M., Lessov, N.S., Dixon, M.P. & Eckenstein, F. Monofilament intraluminal middle cerebral artery occlusion in the mouse. Neurol. Res. 19, 641-648 (1997).
18. Belayev, L., Alonso, O.F., Busto, R., Zhao, W. & Ginsberg, M.D. Middle cerebral artery occlusion in the rat by intraluminal suture. Stroke 27, 1616-1623 (1996).
19. Sha, W.C., Liou, H.-C., Tuomanen, E.I. & Baltimore, D. Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses. Cell 80, 321-330 (1995).
20. Lipton, S.A. & Rosenberg, P.A. Excitatory amino acids as a final common pathway for neurologic disorders. N. Engl. J. Med. 330, 613-22 (1994).
21. Perovic, S., Pialoglou, P., Schröder, H.C., Pergande, G. & Müller, W.E.G. Flupirtine increases the levels of glutathione and Bcl-2 in hNT (human Ntera/D1) neurons: mode of action of the drug-mediated anti-apoptotic effect. Eur. J. Pharmacol. 317, 157-164 (1996).
22. Clemens, J.A., Stephenson, D.T., Smalstig, E.B., Dixon, E.P. & Little, S.P. Global ischemia activates NF-κB in forebrain neurons of rats. Stroke 28, 1073-1081 (1997).
23. Kasibathla, S. et al. DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-κB and AP-1. Mol. Cell 1, 543-551 (1998).
24. Martin-Villalba, A. et al. CD-95-Ligand (Fas-Ligand/ APO-1 L) and TRAIL mediate ischemia-induced apoptosis in neurons. J. Neurosci. (in the press).
25. Kaltschmidt, B., Uherek, M., Volk, B., Baeuerle, P.A. & Kaltschmidt, C. Transcription factor NF-κB is activated in primary neurons by amyloid β peptides and in neurons surrounding early plaques from patients with Alzheimer disease. Proc. Natl. Acad. Sci. USA 94, 2642-2647 (1997).
26. Akama, K.T., Albanese, C., Pestell, R.G. & VanEldik, L.J. Amyloid β-peptide stimulates nitric oxide production in astrocytes through an NF-κB-dependent mechanism. Proc. Natl. Acad. Sci. USA 95, 5795-5800 (1998).
27. Hunot, S. et al. Nuclear translocation of NF-κB is increased in dopaminergic neurons of patients with parkinson disease. Proc. Natl. Acad. Sci. USA 94, 7531-7536 (1997).
28. Carter, B.D. et al. Selective activation of NF-κB by nerve growth factor through the neurotrophin receptor p75. Science 272, 542-545 (1996).
29. Clemens, J.A. et al. Drug-induced neuroprotection from global ischemia is associated with prevention of persistent but not transient activation of NF-κB in rats. Stroke 29, 677-682 (1998).
30. Grilli, M., Pizzi, M., Memo, M. & Spano, P. Neuroprotection by aspirin and sodium salicylate through blockade of NF-κB activation. Science 274, 1383-1385 (1996).
31. Qin, Z.H., Wang, Y., Nakai, M. & Chase, T.N. Nuclear factor-κB contributes to excitotoxin-induced apoptosis in rat striatum. Mol. Pharmacol. 53, 33-42 (1998).
32. Mattson, M.P., Goodman, Y., Luo, H., Fu, W. & Furukawa, K. Activation of NF-kB protects hippocampal neurons against oxidative stress-induced apoptosis: evidence for induction of manganese superoxide dismutase and suppression of peroxynitrite production and protein tyrosine nitration. J. Neurosci. Res. 49, 681-697 (1997).
33. Lezoualc'h, F., Sagara, Y., Holsboer, F. & Behl, C. High constitutive NF-κB activity mediates resistance to oxidative stress in neuronal cells. J. Neurosci. 18, 3224-3232 (1998).
34. Lipton, S.A. Janus faces of NF-κB: Neurodestruction versus neuroprotection. Nature Med. 3, 20-22 (1997).
35. Kopp, E. & Ghosh, S. Inhibition of NF-κB by sodium salicylate and aspirin. Science 265, 956-959 (1994).
36. Schreck, R., Meier, B., Männel, D., Dröge, W. & Baeuerle, P.A. Dithiocarbamates as potent inhibitors of NF-κB activation in intact cells. J. Exp. Med. 175, 1181-1194 (1992).
37. Beyaert, R. et al. The p38/RK mitogen-activated protein kinase pathway regulates interleukin-6 synthesis response to tumor necrosis factor. EMBO J. 15, 1914-1923 (1996).
38. Zwacka, R.M. et al. Redox gene therapy for ischemia / reperfusion injury of the liver reduces AP1 and NF-κB activation. Nature Med. 4, 698-704 (1998).
39. Morishita, R. et al. In vivo transfection of cis element 'decoy' against nuclear NF-κB binding site prevents myocardial infarction. Nature Med. 3, 894-899 (1997).
40. Neurath, M.F., Pettersson, S., Meyer zum Buschenfelde, K.H. & Strober, W. Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-κB abrogates established experimental colitis in mice. Nature Med. 2, 998-1004 (1996).
41. Connolly, E.S., Winfree, C.J., Stern, D.M., Solomon, R.A. & Pinsky, D.J. Procedural and strain-related variables significantly affect outcome in a murine model of focal cerebral ischemia. Neurosurgery 38, 523-531 (1996).
42. Barone, F.C., Knudsen, D.J., Nelson, A.H., Feuerstein, G.Z. & Willette, R.N. Mouse strain differences in susceptibility to cerebral ischemia are related to cerebral vascular anatomy. J. Cereb. Blood Flow Metab. 13, 683-692 (1993).
43. Vogel, J., Mobius, C. & Kuschinsky, W. Early delineation of ischemic tissue in rat brain cryosections by high contrast staining. Stroke (in the press).
44. Swanson, R.A. et al. A semiautomated method for measuring brain infarct volume. J. Cereb. Blood Flow Metab. 10, 290-293 (1990).
45. Dignam, J., Lebovitz, R. & Roeder, R.G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11, 1475-1489 (1983).
46. Weih, F., Carrasco, D. & Bravo, R. Constitutive and inducible Rel/NF-κB activities in mouse thymus and spleen. Oncogene 9, 3289-3297 (1994).